Phathom Pharmaceuticals, Inc. (PHAT)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

100 CAMPUS DRIVE, FLORHAM PARK, NJ 07932

Phathom Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company focuses on development and commercialization for gastrointestinal (GI) diseases and disorder treatments. Phathom Pharmaceuticals serves gastrointestinal and pharmaceutical industries in the State of Illinois.

View SEC Filings from PHAT instead.

View recent insider trading info

Funds Holding PHAT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PHAT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

178.2 Thousand total shares from 3 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

STENHOUSE MARK PRESIDENT, COLOGUARD

  • Officer
29,926 2020-04-02 2

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
3,825,008 2020-04-01 3

YAMADA TADATAKA

  • Director
656,149 2020-03-03 1

COLA MICHAEL F PRESIDENT AND CEO

  • Officer
  • Director
0 2020-02-03 1

FIELDS HEIDI

  • Director
24,850 2020-01-02 1

PARIKH ASIT

  • Director
0 2019-12-02 1

CURRAN TERRIE PRES., GLBL INFLAM. AND IMMUN.

0 2019-11-20 1

FRAZIER LIFE SCIENCES IX, L.P.

TOPPER JAMES N

HERON PATRICK J

FHMLS IX, L.L.C.

FHMLS IX, L.P.

  • Director
  • 10% Owner
7,284,269 2019-10-29 1

EDWARDS JONATHAN S.

  • Director
3,083,091 2019-10-29 2

SOCKS DAVID A PRESIDENT, CEO, TREAS. & SEC.

  • Officer
  • Director
1,686,704 2019-10-24 1

TAKEDA PHARMACEUTICAL CO LTD

  • 10% Owner
1,084,000 2019-10-24 1

KOHLI ADITYA CHIEF BUSINESS OFFICER

  • Officer
843,352 2019-10-24 1

NABULSI AZMI CHIEF OPERATING OFFICER

  • Officer
867,200 2019-10-24 1

SLAVINSKY CHRISTOPHER W.

  • Director
0 2019-10-24 1

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

RA CAPITAL MANAGEMENT, L.P. - > 10% Owner see footnote

RA CAPITAL HEALTHCARE FUND LP - > 10% Owner see footnote

KOLCHINSKY PETER - > 10% Owner see footnote

SHAH RAJEEV M. - > 10% Owner see footnote

2020-04-01 P 117,600 $24.86 a 3,825,008 3,825,008.00 indirect

RA CAPITAL MANAGEMENT, L.P. - > 10% Owner see footnote

RA CAPITAL HEALTHCARE FUND LP - > 10% Owner see footnote

KOLCHINSKY PETER - > 10% Owner see footnote

SHAH RAJEEV M. - > 10% Owner see footnote

2020-03-31 P 30,600 $24.55 a 3,707,408 3,707,408.00 indirect

RA CAPITAL MANAGEMENT, L.P. - > 10% Owner see footnote

RA CAPITAL HEALTHCARE FUND LP - > 10% Owner see footnote

KOLCHINSKY PETER - > 10% Owner see footnote

SHAH RAJEEV M. - > 10% Owner see footnote

2020-03-27 P 30,000 $24.60 a 3,676,808 3,707,408.00 indirect

STENHOUSE MARK - Director

2020-03-17 A 20,000 a 20,000 0.00 direct

Elevate your investments